2,4,6-Triamino-1,3,5-triazine derivative

This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient.It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dem...

Full description

Saved in:
Bibliographic Details
Main Authors Kubota, Hideki, Suzuki, Takeshi, Miura, Masanori, Nakai, Eiichi, Yahiro, Kiyoshi, Miyake, Akira, Mochizuki, Shinobu, Nakatou, Kazuhiro
Format Patent
LanguageEnglish
Published 20.05.2008
Online AccessGet full text

Cover

More Information
Summary:This invention relates to an anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient.It was proved that the BEC 1 potassium channel inhibitor has an action to improve learning disorder and is useful as a preventive or therapeutic agent for diseases, preferably dementia, in which the BEC 1 potassium channel is considered to be concerned.Illustratively, it was confirmed by an in vivo test that the BEC 1 potassium channel inhibitor has an action to improve learning disorder.Also, it was found that a compound having 2,4,6-triamino-1,3,5-triazine has a BEC 1 potassium channel inhibitory action.